Key result
TBX4 gain-of-function missense variants were associated with an older median age at diagnosis of lung disease (57 years) compared to loss-of-function variants (14 years).
Why the study?
Genotype-phenotype associations are lacking despite the increasing frequency of TBX4-associated pulmonary arterial hypertension.
Do specific TBX4 variant types and domains affect the clinical phenotype, age of onset, and survival in patients with pulmonary arterial hypertension?
Cohort (n=137)
Yes
Do specific TBX4 variant types and domains affect the clinical phenotype, age of onset, and survival in patients with pulmonary arterial hypertension?
Absolute Event Rate: 57% vs 14%
p-value: p=0.038
TBX4 syndrome can be caused by gain-of-function mutations, which are associated with older age at diagnosis compared to loss-of-function mutations, highlighting the importance of functional variant assessment in pulmonary arterial hypertension.
Rationale Despite the increasing frequency of TBX4 -associated pulmonary arterial hypertension (PAH), genotype-phenotype associations are lacking and may provide important insights. Methods We assembled a multi-center cohort of 137 patients harboring monoallelic TBX4 variants and assessed the pathogenicity of missense variation (n = 42) using a novel luciferase reporter assay containing T-BOX binding motifs. We sought genotype-phenotype correlations and undertook a comparative analysis with PAH patients with BMPR2 causal variants (n = 162) or no identified variants in PAH-associated genes (n = 741) genotyped via the NIHR BioResource - Rare Diseases (NBR). Results Functional assessment of TBX4 missense variants led to the novel finding of gain-of-function effects associated with older age at diagnosis of lung disease compared to loss-of-function (p = 0.038). Variants located in the T-BOX and nuclear localization domains were associated with earlier presentation (p = 0.005) and increased incidence of interstitial lung disease (p = 0.003). Event-free survival (death or transplantation) was shorter in the T-BOX group (p = 0.022) although age had a significant effect in the hazard model (p = 0.0461). Carriers of TBX4 variants were diagnosed at a younger age (p < 0.001) and had worse baseline lung function (FEV1, FVC) (p = 0.009) compared to the BMPR2 and no identified causal variant groups. Conclusions We demonstrated that TBX4 syndrome is not strictly the result of haploinsufficiency but can also be caused by gain-of-function. The pleiotropic effects of TBX4 in lung disease may be in part explained by the differential effect of pathogenic mutations located in critical protein domains.
No takes yet. Share an insight, caveat, or question.
Prapa et al. (2022) conducted a cohort in TBX4 syndrome (pulmonary arterial hypertension and developmental lung disease) (n=137). TBX4 gain-of-function missense variants vs. TBX4 loss-of-function variants was evaluated on Age at diagnosis of lung disease (median years) (p=0.038). TBX4 gain-of-function missense variants were associated with an older median age at diagnosis of lung disease (57 years) compared to loss-of-function variants (14 years).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: